platelets is one of 59 small molecule programs targeting Thrombocytopenia. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
40 competitors in Thrombocytopenia
Doptelet
Medrol
Innohep
Fragmin
Lovenox
Promacta
Angiomax
Actemra
Mesnex
Tamiflu
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details